MEINA FUNG: Open Payments
NPI 1649575085 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 6 payments from 5 companies in 2025. Trend: 2023 $74 · 2024 $0 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $62 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Geron Corporation | 1 | $25 |
| Kite Pharma, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Cresemba, Enhertu, RYTELO, Yescarta.
Industry payments across NY — which companies pay providers there.
